nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 3A4 Inhibitors—Colchicine—gout	0.514	1	CiPCiCtD
Pazopanib—ABCG2—gout	0.202	1	CbGaD
Pazopanib—UGT1A1—Naproxen—gout	0.043	0.218	CbGbCtD
Pazopanib—UGT1A1—Indomethacin—gout	0.0284	0.144	CbGbCtD
Pazopanib—SLCO1B1—Indomethacin—gout	0.0197	0.0996	CbGbCtD
Pazopanib—CYP2C8—Naproxen—gout	0.0126	0.0638	CbGbCtD
Pazopanib—CYP1A2—Naproxen—gout	0.00976	0.0494	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—gout	0.00964	0.0487	CbGbCtD
Pazopanib—CYP2C8—Colchicine—gout	0.00956	0.0483	CbGbCtD
Pazopanib—CYP2C8—Probenecid—gout	0.00856	0.0433	CbGbCtD
Pazopanib—ABCB1—Colchicine—gout	0.00647	0.0327	CbGbCtD
Pazopanib—ABCB1—Probenecid—gout	0.00579	0.0293	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—gout	0.00572	0.0289	CbGbCtD
Pazopanib—ABCB1—Indomethacin—gout	0.00564	0.0285	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—gout	0.00514	0.026	CbGbCtD
Pazopanib—CYP3A4—Colchicine—gout	0.00388	0.0196	CbGbCtD
Pazopanib—ABCB1—Prednisolone—gout	0.00367	0.0185	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—gout	0.00348	0.0176	CbGbCtD
Pazopanib—CYP3A4—Probenecid—gout	0.00347	0.0175	CbGbCtD
Pazopanib—ABCB1—Prednisone—gout	0.00346	0.0175	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—gout	0.00342	0.0173	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—gout	0.0022	0.0111	CbGbCtD
Pazopanib—Rilpivirine—ABCG2—gout	0.00209	1	CrCbGaD
Pazopanib—CYP3A4—Hydrocortisone—gout	0.00208	0.0105	CbGbCtD
Pazopanib—CYP3A4—Prednisone—gout	0.00207	0.0105	CbGbCtD
Pazopanib—SH2B3—Factors involved in megakaryocyte development and platelet production—LRRC16A—gout	0.00151	0.115	CbGpPWpGaD
Pazopanib—FLT1—HIF-2-alpha transcription factor network—ABCG2—gout	0.000557	0.0423	CbGpPWpGaD
Pazopanib—SH2B3—Hemostasis—LRRC16A—gout	0.000529	0.0402	CbGpPWpGaD
Pazopanib—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.000477	0.0362	CbGpPWpGaD
Pazopanib—UGT1A1—Irinotecan Pathway—ABCG2—gout	0.000456	0.0346	CbGpPWpGaD
Pazopanib—CSF1R—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000429	0.0326	CbGpPWpGaD
Pazopanib—SLCO1B1—Irinotecan Pathway—ABCG2—gout	0.000418	0.0317	CbGpPWpGaD
Pazopanib—FLT1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000416	0.0315	CbGpPWpGaD
Pazopanib—KDR—HIF-2-alpha transcription factor network—ABCG2—gout	0.00037	0.0281	CbGpPWpGaD
Pazopanib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000274	0.0208	CbGpPWpGaD
Pazopanib—FGFR3—Syndecan-3-mediated signaling events—POMC—gout	0.000268	0.0203	CbGpPWpGaD
Pazopanib—TAOK1—MAPK Signaling Pathway—CASP1—gout	0.000252	0.0192	CbGpPWpGaD
Pazopanib—KIT—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000214	0.0163	CbGpPWpGaD
Pazopanib—PDGFRA—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000203	0.0154	CbGpPWpGaD
Pazopanib—PDGFRB—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000183	0.0139	CbGpPWpGaD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—gout	0.000182	0.137	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—gout	0.000182	0.137	CbGdCrCtD
Pazopanib—LYN—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000179	0.0136	CbGpPWpGaD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—gout	0.000172	0.129	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—gout	0.000172	0.129	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisone—gout	0.000157	0.118	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisone—gout	0.000157	0.118	CbGdCrCtD
Pazopanib—PI4KB—Metabolism—BCKDHA—gout	0.000155	0.0118	CbGpPWpGaD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—gout	0.000153	0.115	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisolone—gout	0.000153	0.115	CbGdCrCtD
Pazopanib—ITK—Innate Immune System—NLRP3—gout	0.000141	0.0107	CbGpPWpGaD
Pazopanib—MAP3K2—MAPK Signaling Pathway—CASP1—gout	0.00014	0.0106	CbGpPWpGaD
Pazopanib—UGT1A1—NRF2 pathway—SLC2A9—gout	0.000133	0.0101	CbGpPWpGaD
Pazopanib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000129	0.00979	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—HPRT1—gout	0.000126	0.0096	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—PRPS1—gout	0.000126	0.0096	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—PRPS2—gout	0.000126	0.0096	CbGpPWpGaD
Pazopanib—SLCO1B1—SLC-mediated transmembrane transport—SLC17A1—gout	0.000109	0.00828	CbGpPWpGaD
Pazopanib—SLCO1B1—SLC-mediated transmembrane transport—SLC22A11—gout	0.000109	0.00828	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—LRRC16A—gout	0.000108	0.00818	CbGpPWpGaD
Pazopanib—Hypertension—Naproxen—gout	9.9e-05	0.00143	CcSEcCtD
Pazopanib—Abdominal pain—Colchicine—gout	9.83e-05	0.00142	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Allopurinol—gout	9.77e-05	0.00141	CcSEcCtD
Pazopanib—Arthralgia—Naproxen—gout	9.77e-05	0.00141	CcSEcCtD
Pazopanib—Chest pain—Naproxen—gout	9.77e-05	0.00141	CcSEcCtD
Pazopanib—Myalgia—Naproxen—gout	9.77e-05	0.00141	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	9.7e-05	0.0014	CcSEcCtD
Pazopanib—Insomnia—Allopurinol—gout	9.7e-05	0.0014	CcSEcCtD
Pazopanib—Skin exfoliation—Prednisone—gout	9.67e-05	0.00139	CcSEcCtD
Pazopanib—Gastrointestinal pain—Indomethacin—gout	9.66e-05	0.00139	CcSEcCtD
Pazopanib—Paraesthesia—Allopurinol—gout	9.63e-05	0.00139	CcSEcCtD
Pazopanib—Dry mouth—Naproxen—gout	9.55e-05	0.00138	CcSEcCtD
Pazopanib—Somnolence—Allopurinol—gout	9.53e-05	0.00137	CcSEcCtD
Pazopanib—Cardiac failure—Methylprednisolone—gout	9.51e-05	0.00137	CcSEcCtD
Pazopanib—Dyspepsia—Allopurinol—gout	9.44e-05	0.00136	CcSEcCtD
Pazopanib—Oedema—Naproxen—gout	9.36e-05	0.00135	CcSEcCtD
Pazopanib—Abdominal pain—Indomethacin—gout	9.34e-05	0.00135	CcSEcCtD
Pazopanib—Decreased appetite—Allopurinol—gout	9.32e-05	0.00134	CcSEcCtD
Pazopanib—Infection—Naproxen—gout	9.3e-05	0.00134	CcSEcCtD
Pazopanib—Dry skin—Prednisolone—gout	9.27e-05	0.00134	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Allopurinol—gout	9.26e-05	0.00133	CcSEcCtD
Pazopanib—MAP2K5—MAPK Signaling Pathway—CASP1—gout	9.25e-05	0.00703	CbGpPWpGaD
Pazopanib—Shock—Naproxen—gout	9.21e-05	0.00133	CcSEcCtD
Pazopanib—Nervous system disorder—Naproxen—gout	9.18e-05	0.00132	CcSEcCtD
Pazopanib—Pain—Allopurinol—gout	9.17e-05	0.00132	CcSEcCtD
Pazopanib—Thrombocytopenia—Naproxen—gout	9.17e-05	0.00132	CcSEcCtD
Pazopanib—Skin disorder—Naproxen—gout	9.09e-05	0.00131	CcSEcCtD
Pazopanib—Dry skin—Hydrocortisone—gout	9.05e-05	0.0013	CcSEcCtD
Pazopanib—Hyperhidrosis—Naproxen—gout	9.05e-05	0.0013	CcSEcCtD
Pazopanib—Abdominal pain upper—Hydrocortisone—gout	9.02e-05	0.0013	CcSEcCtD
Pazopanib—Anorexia—Naproxen—gout	8.92e-05	0.00129	CcSEcCtD
Pazopanib—Asthenia—Colchicine—gout	8.92e-05	0.00129	CcSEcCtD
Pazopanib—LCK—Hemostasis—LRRC16A—gout	8.83e-05	0.00671	CbGpPWpGaD
Pazopanib—Abdominal distension—Prednisolone—gout	8.8e-05	0.00127	CcSEcCtD
Pazopanib—Gastrointestinal pain—Allopurinol—gout	8.77e-05	0.00126	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Hydrocortisone—gout	8.71e-05	0.00125	CcSEcCtD
Pazopanib—Abdominal distension—Hydrocortisone—gout	8.6e-05	0.00124	CcSEcCtD
Pazopanib—Pancreatitis—Prednisolone—gout	8.57e-05	0.00123	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Naproxen—gout	8.53e-05	0.00123	CcSEcCtD
Pazopanib—Diarrhoea—Colchicine—gout	8.51e-05	0.00123	CcSEcCtD
Pazopanib—Asthenia—Indomethacin—gout	8.48e-05	0.00122	CcSEcCtD
Pazopanib—Abdominal pain—Allopurinol—gout	8.48e-05	0.00122	CcSEcCtD
Pazopanib—Insomnia—Naproxen—gout	8.47e-05	0.00122	CcSEcCtD
Pazopanib—Paraesthesia—Naproxen—gout	8.41e-05	0.00121	CcSEcCtD
Pazopanib—Breast disorder—Methylprednisolone—gout	8.39e-05	0.00121	CcSEcCtD
Pazopanib—Pancreatitis—Hydrocortisone—gout	8.37e-05	0.00121	CcSEcCtD
Pazopanib—Pruritus—Indomethacin—gout	8.36e-05	0.0012	CcSEcCtD
Pazopanib—Dyspnoea—Naproxen—gout	8.35e-05	0.0012	CcSEcCtD
Pazopanib—Somnolence—Naproxen—gout	8.32e-05	0.0012	CcSEcCtD
Pazopanib—LYN—Signaling by Interleukins—CASP1—gout	8.31e-05	0.00631	CbGpPWpGaD
Pazopanib—SLCO1B1—SLC-mediated transmembrane transport—SLC22A12—gout	8.27e-05	0.00628	CbGpPWpGaD
Pazopanib—Dyspepsia—Naproxen—gout	8.24e-05	0.00119	CcSEcCtD
Pazopanib—ITK—Immune System—NLRP3—gout	8.21e-05	0.00623	CbGpPWpGaD
Pazopanib—Alanine aminotransferase increased—Methylprednisolone—gout	8.19e-05	0.00118	CcSEcCtD
Pazopanib—Decreased appetite—Naproxen—gout	8.14e-05	0.00117	CcSEcCtD
Pazopanib—Cardiac failure congestive—Prednisone—gout	8.1e-05	0.00117	CcSEcCtD
Pazopanib—Diarrhoea—Indomethacin—gout	8.08e-05	0.00116	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Naproxen—gout	8.08e-05	0.00116	CcSEcCtD
Pazopanib—Abdominal distension—Methylprednisolone—gout	8.08e-05	0.00116	CcSEcCtD
Pazopanib—Fatigue—Naproxen—gout	8.07e-05	0.00116	CcSEcCtD
Pazopanib—LYN—Signaling by Interleukins—IL1RN—gout	8.05e-05	0.00611	CbGpPWpGaD
Pazopanib—Pain—Naproxen—gout	8.01e-05	0.00115	CcSEcCtD
Pazopanib—Vomiting—Colchicine—gout	7.91e-05	0.00114	CcSEcCtD
Pazopanib—FGFR3—Innate Immune System—NLRP3—gout	7.9e-05	0.006	CbGpPWpGaD
Pazopanib—Pancreatitis—Methylprednisolone—gout	7.86e-05	0.00113	CcSEcCtD
Pazopanib—Rash—Colchicine—gout	7.84e-05	0.00113	CcSEcCtD
Pazopanib—Dermatitis—Colchicine—gout	7.83e-05	0.00113	CcSEcCtD
Pazopanib—Dizziness—Indomethacin—gout	7.81e-05	0.00113	CcSEcCtD
Pazopanib—Headache—Colchicine—gout	7.79e-05	0.00112	CcSEcCtD
Pazopanib—Weight decreased—Hydrocortisone—gout	7.72e-05	0.00111	CcSEcCtD
Pazopanib—Asthenia—Allopurinol—gout	7.69e-05	0.00111	CcSEcCtD
Pazopanib—SLCO1B1—SLC-mediated transmembrane transport—SLC2A9—gout	7.69e-05	0.00584	CbGpPWpGaD
Pazopanib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	7.68e-05	0.00583	CbGpPWpGaD
Pazopanib—Acute coronary syndrome—Prednisolone—gout	7.68e-05	0.00111	CcSEcCtD
Pazopanib—Gastrointestinal pain—Naproxen—gout	7.65e-05	0.0011	CcSEcCtD
Pazopanib—Myocardial infarction—Prednisolone—gout	7.64e-05	0.0011	CcSEcCtD
Pazopanib—Infestation NOS—Hydrocortisone—gout	7.61e-05	0.0011	CcSEcCtD
Pazopanib—Infestation—Hydrocortisone—gout	7.61e-05	0.0011	CcSEcCtD
Pazopanib—Pruritus—Allopurinol—gout	7.59e-05	0.00109	CcSEcCtD
Pazopanib—Cardiac failure—Prednisone—gout	7.53e-05	0.00108	CcSEcCtD
Pazopanib—Vomiting—Indomethacin—gout	7.51e-05	0.00108	CcSEcCtD
Pazopanib—Acute coronary syndrome—Hydrocortisone—gout	7.5e-05	0.00108	CcSEcCtD
Pazopanib—Lethargy—Prednisone—gout	7.5e-05	0.00108	CcSEcCtD
Pazopanib—Myocardial infarction—Hydrocortisone—gout	7.46e-05	0.00107	CcSEcCtD
Pazopanib—Rash—Indomethacin—gout	7.45e-05	0.00107	CcSEcCtD
Pazopanib—Dermatitis—Indomethacin—gout	7.44e-05	0.00107	CcSEcCtD
Pazopanib—Headache—Indomethacin—gout	7.4e-05	0.00107	CcSEcCtD
Pazopanib—Abdominal pain—Naproxen—gout	7.4e-05	0.00107	CcSEcCtD
Pazopanib—Nausea—Colchicine—gout	7.39e-05	0.00106	CcSEcCtD
Pazopanib—Gastrointestinal haemorrhage—Prednisone—gout	7.35e-05	0.00106	CcSEcCtD
Pazopanib—Diarrhoea—Allopurinol—gout	7.34e-05	0.00106	CcSEcCtD
Pazopanib—Infestation NOS—Methylprednisolone—gout	7.15e-05	0.00103	CcSEcCtD
Pazopanib—Infestation—Methylprednisolone—gout	7.15e-05	0.00103	CcSEcCtD
Pazopanib—Bradycardia—Prednisolone—gout	7.12e-05	0.00103	CcSEcCtD
Pazopanib—Face oedema—Prednisone—gout	7.1e-05	0.00102	CcSEcCtD
Pazopanib—Dizziness—Allopurinol—gout	7.09e-05	0.00102	CcSEcCtD
Pazopanib—Acute coronary syndrome—Methylprednisolone—gout	7.05e-05	0.00102	CcSEcCtD
Pazopanib—Haemoglobin—Prednisolone—gout	7.03e-05	0.00101	CcSEcCtD
Pazopanib—Nausea—Indomethacin—gout	7.02e-05	0.00101	CcSEcCtD
Pazopanib—Myocardial infarction—Methylprednisolone—gout	7.01e-05	0.00101	CcSEcCtD
Pazopanib—Haemorrhage—Prednisolone—gout	7e-05	0.00101	CcSEcCtD
Pazopanib—Bradycardia—Hydrocortisone—gout	6.96e-05	0.001	CcSEcCtD
Pazopanib—ITK—Innate Immune System—CASP1—gout	6.88e-05	0.00522	CbGpPWpGaD
Pazopanib—Haemoglobin—Hydrocortisone—gout	6.87e-05	0.000989	CcSEcCtD
Pazopanib—Haemorrhage—Hydrocortisone—gout	6.83e-05	0.000984	CcSEcCtD
Pazopanib—Vomiting—Allopurinol—gout	6.82e-05	0.000982	CcSEcCtD
Pazopanib—LCK—Signaling by Interleukins—CASP1—gout	6.81e-05	0.00517	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC17A3—gout	6.8e-05	0.00516	CbGpPWpGaD
Pazopanib—Rash—Allopurinol—gout	6.76e-05	0.000974	CcSEcCtD
Pazopanib—Dermatitis—Allopurinol—gout	6.75e-05	0.000973	CcSEcCtD
Pazopanib—Dry skin—Prednisone—gout	6.74e-05	0.00097	CcSEcCtD
Pazopanib—Headache—Allopurinol—gout	6.72e-05	0.000968	CcSEcCtD
Pazopanib—Asthenia—Naproxen—gout	6.72e-05	0.000967	CcSEcCtD
Pazopanib—Connective tissue disorder—Hydrocortisone—gout	6.72e-05	0.000967	CcSEcCtD
Pazopanib—FGFR1—MAPK Signaling Pathway—CASP1—gout	6.64e-05	0.00504	CbGpPWpGaD
Pazopanib—Pruritus—Naproxen—gout	6.62e-05	0.000954	CcSEcCtD
Pazopanib—LCK—Signaling by Interleukins—IL1RN—gout	6.6e-05	0.00501	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—NLRP3—gout	6.56e-05	0.00498	CbGpPWpGaD
Pazopanib—Bradycardia—Methylprednisolone—gout	6.54e-05	0.000941	CcSEcCtD
Pazopanib—Alanine aminotransferase increased—Prednisone—gout	6.48e-05	0.000934	CcSEcCtD
Pazopanib—Haemoglobin—Methylprednisolone—gout	6.45e-05	0.00093	CcSEcCtD
Pazopanib—Haemorrhage—Methylprednisolone—gout	6.42e-05	0.000925	CcSEcCtD
Pazopanib—FGFR3—Disease—PRPS1—gout	6.41e-05	0.00487	CbGpPWpGaD
Pazopanib—FGFR3—Disease—PRPS2—gout	6.41e-05	0.00487	CbGpPWpGaD
Pazopanib—Diarrhoea—Naproxen—gout	6.4e-05	0.000923	CcSEcCtD
Pazopanib—Abdominal distension—Prednisone—gout	6.4e-05	0.000921	CcSEcCtD
Pazopanib—Eye disorder—Hydrocortisone—gout	6.39e-05	0.00092	CcSEcCtD
Pazopanib—Nausea—Allopurinol—gout	6.37e-05	0.000917	CcSEcCtD
Pazopanib—Connective tissue disorder—Methylprednisolone—gout	6.31e-05	0.000909	CcSEcCtD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	6.3e-05	0.00478	CbGpPWpGaD
Pazopanib—Pancreatitis—Prednisone—gout	6.23e-05	0.000897	CcSEcCtD
Pazopanib—Dizziness—Naproxen—gout	6.19e-05	0.000892	CcSEcCtD
Pazopanib—Erythema—Prednisolone—gout	6.09e-05	0.000877	CcSEcCtD
Pazopanib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	6.06e-05	0.0046	CbGpPWpGaD
Pazopanib—Eye disorder—Methylprednisolone—gout	6e-05	0.000864	CcSEcCtD
Pazopanib—Mental disorder—Hydrocortisone—gout	5.99e-05	0.000862	CcSEcCtD
Pazopanib—PDGFRB—MAPK Signaling Pathway—CASP1—gout	5.96e-05	0.00453	CbGpPWpGaD
Pazopanib—Cardiac disorder—Methylprednisolone—gout	5.96e-05	0.000858	CcSEcCtD
Pazopanib—Vomiting—Naproxen—gout	5.95e-05	0.000857	CcSEcCtD
Pazopanib—Malnutrition—Hydrocortisone—gout	5.95e-05	0.000857	CcSEcCtD
Pazopanib—Erythema—Hydrocortisone—gout	5.95e-05	0.000857	CcSEcCtD
Pazopanib—Neutropenia—Prednisone—gout	5.94e-05	0.000856	CcSEcCtD
Pazopanib—Rash—Naproxen—gout	5.9e-05	0.00085	CcSEcCtD
Pazopanib—Dermatitis—Naproxen—gout	5.9e-05	0.000849	CcSEcCtD
Pazopanib—Headache—Naproxen—gout	5.86e-05	0.000845	CcSEcCtD
Pazopanib—Angiopathy—Methylprednisolone—gout	5.83e-05	0.000839	CcSEcCtD
Pazopanib—Mediastinal disorder—Methylprednisolone—gout	5.79e-05	0.000833	CcSEcCtD
Pazopanib—Weight decreased—Prednisone—gout	5.75e-05	0.000828	CcSEcCtD
Pazopanib—Vision blurred—Prednisolone—gout	5.74e-05	0.000827	CcSEcCtD
Pazopanib—Mental disorder—Methylprednisolone—gout	5.62e-05	0.00081	CcSEcCtD
Pazopanib—Malnutrition—Methylprednisolone—gout	5.59e-05	0.000805	CcSEcCtD
Pazopanib—Erythema—Methylprednisolone—gout	5.59e-05	0.000805	CcSEcCtD
Pazopanib—Acute coronary syndrome—Prednisone—gout	5.58e-05	0.000804	CcSEcCtD
Pazopanib—Nausea—Naproxen—gout	5.56e-05	0.000801	CcSEcCtD
Pazopanib—Myocardial infarction—Prednisone—gout	5.55e-05	0.0008	CcSEcCtD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC22A11—gout	5.55e-05	0.00421	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC17A1—gout	5.55e-05	0.00421	CbGpPWpGaD
Pazopanib—Syncope—Prednisolone—gout	5.46e-05	0.000787	CcSEcCtD
Pazopanib—FGFR2—Innate Immune System—NLRP3—gout	5.43e-05	0.00412	CbGpPWpGaD
Pazopanib—Loss of consciousness—Prednisolone—gout	5.35e-05	0.000771	CcSEcCtD
Pazopanib—KIT—Innate Immune System—NLRP3—gout	5.34e-05	0.00405	CbGpPWpGaD
Pazopanib—Syncope—Hydrocortisone—gout	5.33e-05	0.000768	CcSEcCtD
Pazopanib—FGF1—Disease—PRPS2—gout	5.33e-05	0.00405	CbGpPWpGaD
Pazopanib—FGF1—Disease—PRPS1—gout	5.33e-05	0.00405	CbGpPWpGaD
Pazopanib—Hypertension—Prednisolone—gout	5.26e-05	0.000758	CcSEcCtD
Pazopanib—Loss of consciousness—Hydrocortisone—gout	5.23e-05	0.000753	CcSEcCtD
Pazopanib—Bradycardia—Prednisone—gout	5.18e-05	0.000746	CcSEcCtD
Pazopanib—Hypertension—Hydrocortisone—gout	5.14e-05	0.00074	CcSEcCtD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	5.13e-05	0.0039	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	5.13e-05	0.0039	CbGpPWpGaD
Pazopanib—Haemoglobin—Prednisone—gout	5.11e-05	0.000736	CcSEcCtD
Pazopanib—Haemorrhage—Prednisone—gout	5.08e-05	0.000732	CcSEcCtD
Pazopanib—Myalgia—Hydrocortisone—gout	5.06e-05	0.00073	CcSEcCtD
Pazopanib—FGFR1—Innate Immune System—NLRP3—gout	5.06e-05	0.00384	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—NLRP3—gout	5.05e-05	0.00383	CbGpPWpGaD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	5.03e-05	0.000725	CcSEcCtD
Pazopanib—Syncope—Methylprednisolone—gout	5.01e-05	0.000722	CcSEcCtD
Pazopanib—Connective tissue disorder—Prednisone—gout	5e-05	0.00072	CcSEcCtD
Pazopanib—Oedema—Prednisolone—gout	4.97e-05	0.000716	CcSEcCtD
Pazopanib—Loss of consciousness—Methylprednisolone—gout	4.91e-05	0.000708	CcSEcCtD
Pazopanib—Shock—Prednisolone—gout	4.89e-05	0.000704	CcSEcCtD
Pazopanib—Oedema—Hydrocortisone—gout	4.86e-05	0.000699	CcSEcCtD
Pazopanib—Hypertension—Methylprednisolone—gout	4.83e-05	0.000695	CcSEcCtD
Pazopanib—Infection—Hydrocortisone—gout	4.82e-05	0.000695	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisolone—gout	4.81e-05	0.000692	CcSEcCtD
Pazopanib—Shock—Hydrocortisone—gout	4.78e-05	0.000688	CcSEcCtD
Pazopanib—Nervous system disorder—Hydrocortisone—gout	4.76e-05	0.000686	CcSEcCtD
Pazopanib—Myalgia—Methylprednisolone—gout	4.76e-05	0.000685	CcSEcCtD
Pazopanib—Arthralgia—Methylprednisolone—gout	4.76e-05	0.000685	CcSEcCtD
Pazopanib—Eye disorder—Prednisone—gout	4.75e-05	0.000684	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	4.73e-05	0.000681	CcSEcCtD
Pazopanib—Flushing—Prednisone—gout	4.72e-05	0.00068	CcSEcCtD
Pazopanib—Skin disorder—Hydrocortisone—gout	4.72e-05	0.000679	CcSEcCtD
Pazopanib—Hyperhidrosis—Hydrocortisone—gout	4.69e-05	0.000676	CcSEcCtD
Pazopanib—PI4KB—Metabolism—ABCG2—gout	4.68e-05	0.00355	CbGpPWpGaD
Pazopanib—Anorexia—Hydrocortisone—gout	4.63e-05	0.000667	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—gout	4.61e-05	0.000664	CcSEcCtD
Pazopanib—FGFR3—Immune System—NLRP3—gout	4.6e-05	0.00349	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—NLRP3—gout	4.55e-05	0.00345	CbGpPWpGaD
Pazopanib—Infection—Methylprednisolone—gout	4.53e-05	0.000653	CcSEcCtD
Pazopanib—PI4KB—Metabolism of lipids and lipoproteins—POMC—gout	4.5e-05	0.00342	CbGpPWpGaD
Pazopanib—Insomnia—Prednisolone—gout	4.5e-05	0.000648	CcSEcCtD
Pazopanib—Alopecia—Prednisone—gout	4.49e-05	0.000647	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—gout	4.49e-05	0.000646	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—gout	4.47e-05	0.000644	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—gout	4.46e-05	0.000643	CcSEcCtD
Pazopanib—LYN—Innate Immune System—NLRP3—gout	4.46e-05	0.00338	CbGpPWpGaD
Pazopanib—Mental disorder—Prednisone—gout	4.45e-05	0.000642	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—gout	4.43e-05	0.000638	CcSEcCtD
Pazopanib—Erythema—Prednisone—gout	4.43e-05	0.000638	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—gout	4.43e-05	0.000638	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—gout	4.42e-05	0.000637	CcSEcCtD
Pazopanib—FGFR2—Disease—PRPS1—gout	4.41e-05	0.00335	CbGpPWpGaD
Pazopanib—FGFR2—Disease—PRPS2—gout	4.41e-05	0.00335	CbGpPWpGaD
Pazopanib—Hyperhidrosis—Methylprednisolone—gout	4.41e-05	0.000635	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—gout	4.39e-05	0.000633	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—gout	4.36e-05	0.000628	CcSEcCtD
Pazopanib—KIT—Disease—PRPS2—gout	4.33e-05	0.00329	CbGpPWpGaD
Pazopanib—KIT—Disease—PRPS1—gout	4.33e-05	0.00329	CbGpPWpGaD
Pazopanib—Dyspepsia—Hydrocortisone—gout	4.27e-05	0.000616	CcSEcCtD
Pazopanib—Pain—Prednisolone—gout	4.25e-05	0.000612	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—gout	4.22e-05	0.000608	CcSEcCtD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC22A12—gout	4.2e-05	0.00319	CbGpPWpGaD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—gout	4.19e-05	0.000604	CcSEcCtD
Pazopanib—Fatigue—Hydrocortisone—gout	4.19e-05	0.000603	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—gout	4.17e-05	0.000601	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—gout	4.16e-05	0.000599	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—gout	4.15e-05	0.000598	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—gout	4.13e-05	0.000594	CcSEcCtD
Pazopanib—FGFR1—Disease—PRPS2—gout	4.11e-05	0.00312	CbGpPWpGaD
Pazopanib—FGFR1—Disease—PRPS1—gout	4.11e-05	0.00312	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PRPS1—gout	4.1e-05	0.00311	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—PRPS2—gout	4.1e-05	0.00311	CbGpPWpGaD
Pazopanib—Paraesthesia—Methylprednisolone—gout	4.1e-05	0.00059	CcSEcCtD
Pazopanib—Anaemia—Prednisone—gout	4.09e-05	0.000589	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—gout	4.02e-05	0.000578	CcSEcCtD
Pazopanib—ITK—Immune System—CASP1—gout	4.01e-05	0.00304	CbGpPWpGaD
Pazopanib—Gastrointestinal pain—Hydrocortisone—gout	3.97e-05	0.000572	CcSEcCtD
Pazopanib—Syncope—Prednisone—gout	3.97e-05	0.000572	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—gout	3.93e-05	0.000566	CcSEcCtD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC2A9—gout	3.91e-05	0.00297	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	3.89e-05	0.00295	CbGpPWpGaD
Pazopanib—Loss of consciousness—Prednisone—gout	3.89e-05	0.00056	CcSEcCtD
Pazopanib—ITK—Immune System—IL1RN—gout	3.88e-05	0.00295	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—CASP1—gout	3.88e-05	0.00295	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—CASP1—gout	3.86e-05	0.00293	CbGpPWpGaD
Pazopanib—Abdominal pain—Hydrocortisone—gout	3.84e-05	0.000553	CcSEcCtD
Pazopanib—FGF1—Immune System—NLRP3—gout	3.82e-05	0.0029	CbGpPWpGaD
Pazopanib—Hypertension—Prednisone—gout	3.82e-05	0.00055	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—gout	3.77e-05	0.000543	CcSEcCtD
Pazopanib—Myalgia—Prednisone—gout	3.77e-05	0.000543	CcSEcCtD
Pazopanib—LYN—Cytokine Signaling in Immune system—IL1RN—gout	3.76e-05	0.00285	CbGpPWpGaD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	3.74e-05	0.000539	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—gout	3.73e-05	0.000537	CcSEcCtD
Pazopanib—PDGFRB—Disease—PRPS2—gout	3.69e-05	0.0028	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PRPS1—gout	3.69e-05	0.0028	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—NLRP3—gout	3.65e-05	0.00277	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	3.62e-05	0.00275	CbGpPWpGaD
Pazopanib—Oedema—Prednisone—gout	3.61e-05	0.00052	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—gout	3.61e-05	0.000519	CcSEcCtD
Pazopanib—Infection—Prednisone—gout	3.59e-05	0.000517	CcSEcCtD
Pazopanib—Shock—Prednisone—gout	3.55e-05	0.000512	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—gout	3.54e-05	0.00051	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—gout	3.51e-05	0.000505	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—gout	3.49e-05	0.000503	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—gout	3.48e-05	0.000502	CcSEcCtD
Pazopanib—UGT1A1—Metabolism—BCKDHA—gout	3.48e-05	0.00264	CbGpPWpGaD
Pazopanib—Anorexia—Prednisone—gout	3.44e-05	0.000496	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—gout	3.43e-05	0.000495	CcSEcCtD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	3.41e-05	0.00259	CbGpPWpGaD
Pazopanib—Diarrhoea—Hydrocortisone—gout	3.32e-05	0.000478	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—gout	3.29e-05	0.000474	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—gout	3.29e-05	0.000474	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—gout	3.27e-05	0.000471	CcSEcCtD
Pazopanib—Insomnia—Prednisone—gout	3.27e-05	0.000471	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—gout	3.24e-05	0.000467	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—gout	3.23e-05	0.000465	CcSEcCtD
Pazopanib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	3.21e-05	0.00244	CbGpPWpGaD
Pazopanib—Dizziness—Hydrocortisone—gout	3.21e-05	0.000462	CcSEcCtD
Pazopanib—FGF1—Innate Immune System—CASP1—gout	3.21e-05	0.00243	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—BCKDHA—gout	3.19e-05	0.00242	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—CASP1—gout	3.18e-05	0.00241	CbGpPWpGaD
Pazopanib—Dyspepsia—Prednisone—gout	3.18e-05	0.000458	CcSEcCtD
Pazopanib—FGFR2—Immune System—NLRP3—gout	3.16e-05	0.0024	CbGpPWpGaD
Pazopanib—Decreased appetite—Prednisone—gout	3.14e-05	0.000452	CcSEcCtD
Pazopanib—Rash—Prednisolone—gout	3.13e-05	0.000451	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—gout	3.13e-05	0.000451	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—gout	3.12e-05	0.00045	CcSEcCtD
Pazopanib—Fatigue—Prednisone—gout	3.11e-05	0.000449	CcSEcCtD
Pazopanib—Headache—Prednisolone—gout	3.11e-05	0.000449	CcSEcCtD
Pazopanib—KIT—Immune System—NLRP3—gout	3.11e-05	0.00236	CbGpPWpGaD
Pazopanib—Vomiting—Hydrocortisone—gout	3.09e-05	0.000445	CcSEcCtD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL1RN—gout	3.08e-05	0.00234	CbGpPWpGaD
Pazopanib—Rash—Hydrocortisone—gout	3.06e-05	0.000441	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—gout	3.06e-05	0.000441	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—gout	3.04e-05	0.000438	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—gout	3.02e-05	0.000434	CcSEcCtD
Pazopanib—LCK—Disease—PRPS1—gout	2.96e-05	0.00225	CbGpPWpGaD
Pazopanib—LCK—Disease—PRPS2—gout	2.96e-05	0.00225	CbGpPWpGaD
Pazopanib—Gastrointestinal pain—Prednisone—gout	2.95e-05	0.000425	CcSEcCtD
Pazopanib—Nausea—Prednisolone—gout	2.95e-05	0.000425	CcSEcCtD
Pazopanib—ABCG2—Metabolism—BCKDHA—gout	2.95e-05	0.00224	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NLRP3—gout	2.95e-05	0.00224	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NLRP3—gout	2.94e-05	0.00223	CbGpPWpGaD
Pazopanib—Vomiting—Methylprednisolone—gout	2.9e-05	0.000418	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—gout	2.88e-05	0.000415	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—gout	2.88e-05	0.000414	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—gout	2.87e-05	0.000414	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—gout	2.86e-05	0.000412	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—gout	2.86e-05	0.000411	CcSEcCtD
Pazopanib—UGT1A1—Metabolism—PRPS1—gout	2.83e-05	0.00215	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PRPS2—gout	2.83e-05	0.00215	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—HPRT1—gout	2.83e-05	0.00215	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	2.78e-05	0.00211	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	2.78e-05	0.00211	CbGpPWpGaD
Pazopanib—Nausea—Methylprednisolone—gout	2.71e-05	0.00039	CcSEcCtD
Pazopanib—FGFR2—Innate Immune System—CASP1—gout	2.65e-05	0.00201	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NLRP3—gout	2.65e-05	0.00201	CbGpPWpGaD
Pazopanib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	2.64e-05	0.002	CbGpPWpGaD
Pazopanib—UGT1A1—Biological oxidations—POMC—gout	2.63e-05	0.00199	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—CASP1—gout	2.61e-05	0.00198	CbGpPWpGaD
Pazopanib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	2.6e-05	0.00198	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PRPS1—gout	2.6e-05	0.00197	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PRPS2—gout	2.6e-05	0.00197	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—HPRT1—gout	2.6e-05	0.00197	CbGpPWpGaD
Pazopanib—LYN—Immune System—NLRP3—gout	2.59e-05	0.00197	CbGpPWpGaD
Pazopanib—Asthenia—Prednisone—gout	2.59e-05	0.000373	CcSEcCtD
Pazopanib—Pruritus—Prednisone—gout	2.56e-05	0.000368	CcSEcCtD
Pazopanib—FGFR1—Innate Immune System—CASP1—gout	2.47e-05	0.00188	CbGpPWpGaD
Pazopanib—Diarrhoea—Prednisone—gout	2.47e-05	0.000356	CcSEcCtD
Pazopanib—PDGFRA—Innate Immune System—CASP1—gout	2.47e-05	0.00187	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—HPRT1—gout	2.41e-05	0.00183	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PRPS2—gout	2.41e-05	0.00183	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PRPS1—gout	2.41e-05	0.00183	CbGpPWpGaD
Pazopanib—Dizziness—Prednisone—gout	2.39e-05	0.000344	CcSEcCtD
Pazopanib—Vomiting—Prednisone—gout	2.3e-05	0.000331	CcSEcCtD
Pazopanib—Rash—Prednisone—gout	2.28e-05	0.000328	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—gout	2.28e-05	0.000328	CcSEcCtD
Pazopanib—Headache—Prednisone—gout	2.26e-05	0.000326	CcSEcCtD
Pazopanib—FGFR3—Immune System—CASP1—gout	2.25e-05	0.00171	CbGpPWpGaD
Pazopanib—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	2.23e-05	0.0017	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—CASP1—gout	2.22e-05	0.00169	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL1RN—gout	2.18e-05	0.00165	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—CASP1—gout	2.18e-05	0.00165	CbGpPWpGaD
Pazopanib—Nausea—Prednisone—gout	2.15e-05	0.000309	CcSEcCtD
Pazopanib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	2.14e-05	0.00162	CbGpPWpGaD
Pazopanib—LCK—Immune System—NLRP3—gout	2.13e-05	0.00161	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	2.1e-05	0.0016	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—ABCG2—gout	2.05e-05	0.00156	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—POMC—gout	2e-05	0.00152	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—POMC—gout	1.97e-05	0.0015	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	1.96e-05	0.00148	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CASP1—gout	1.87e-05	0.00142	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—BCKDHA—gout	1.83e-05	0.00139	CbGpPWpGaD
Pazopanib—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	1.81e-05	0.00137	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL1RN—gout	1.81e-05	0.00137	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CASP1—gout	1.78e-05	0.00135	CbGpPWpGaD
Pazopanib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	1.72e-05	0.00131	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—BCKDHA—gout	1.6e-05	0.00121	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CASP1—gout	1.55e-05	0.00117	CbGpPWpGaD
Pazopanib—KIT—Immune System—CASP1—gout	1.52e-05	0.00115	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—BCKDHA—gout	1.5e-05	0.00114	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL1RN—gout	1.5e-05	0.00114	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PRPS2—gout	1.49e-05	0.00113	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HPRT1—gout	1.49e-05	0.00113	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PRPS1—gout	1.49e-05	0.00113	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL1RN—gout	1.47e-05	0.00112	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CASP1—gout	1.44e-05	0.00109	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CASP1—gout	1.44e-05	0.00109	CbGpPWpGaD
Pazopanib—SH2B3—tendon—gout	1.41e-05	0.0947	CbGeAlD
Pazopanib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	1.4e-05	0.00106	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1RN—gout	1.39e-05	0.00106	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1RN—gout	1.39e-05	0.00106	CbGpPWpGaD
Pazopanib—AURKC—tendon—gout	1.39e-05	0.0933	CbGeAlD
Pazopanib—CYP2C8—Biological oxidations—POMC—gout	1.38e-05	0.00105	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—POMC—gout	1.37e-05	0.00104	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PRPS1—gout	1.3e-05	0.000987	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HPRT1—gout	1.3e-05	0.000987	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PRPS2—gout	1.3e-05	0.000987	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CASP1—gout	1.29e-05	0.000983	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—BCKDHA—gout	1.27e-05	0.000967	CbGpPWpGaD
Pazopanib—LYN—Immune System—CASP1—gout	1.27e-05	0.000962	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1RN—gout	1.25e-05	0.000952	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—POMC—gout	1.25e-05	0.000948	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1RN—gout	1.23e-05	0.000932	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HPRT1—gout	1.23e-05	0.00093	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PRPS2—gout	1.23e-05	0.00093	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PRPS1—gout	1.23e-05	0.00093	CbGpPWpGaD
Pazopanib—STK16—tendon—gout	1.2e-05	0.0806	CbGeAlD
Pazopanib—RIOK2—tendon—gout	1.18e-05	0.0793	CbGeAlD
Pazopanib—CYP2D6—Biological oxidations—POMC—gout	1.14e-05	0.000862	CbGpPWpGaD
Pazopanib—STK36—tendon—gout	1.06e-05	0.0712	CbGeAlD
Pazopanib—UGT1A1—Metabolism—ABCG2—gout	1.05e-05	0.000796	CbGpPWpGaD
Pazopanib—PI4KB—tendon—gout	1.04e-05	0.0701	CbGeAlD
Pazopanib—LCK—Immune System—CASP1—gout	1.04e-05	0.000789	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HPRT1—gout	1.04e-05	0.000788	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PRPS1—gout	1.04e-05	0.000788	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PRPS2—gout	1.04e-05	0.000788	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	1.03e-05	0.00078	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1RN—gout	1.01e-05	0.000764	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BCKDHA—gout	9.83e-06	0.000746	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—POMC—gout	9.62e-06	0.00073	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ABCG2—gout	9.61e-06	0.00073	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—POMC—gout	9.32e-06	0.000707	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—gout	9.24e-06	0.000702	CbGpPWpGaD
Pazopanib—PIP4K2C—tendon—gout	9.15e-06	0.0615	CbGeAlD
Pazopanib—FGFR1—tendon—gout	9.07e-06	0.061	CbGeAlD
Pazopanib—CYP3A4—Metabolism—PRPS2—gout	8.01e-06	0.000608	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HPRT1—gout	8.01e-06	0.000608	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PRPS1—gout	8.01e-06	0.000608	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—POMC—gout	7.42e-06	0.000564	CbGpPWpGaD
Pazopanib—FLT1—tendon—gout	7.15e-06	0.0481	CbGeAlD
Pazopanib—FGFR3—Signaling Pathways—POMC—gout	7.12e-06	0.00054	CbGpPWpGaD
Pazopanib—EPHB6—tendon—gout	7.07e-06	0.0476	CbGeAlD
Pazopanib—STK10—tendon—gout	6.77e-06	0.0455	CbGeAlD
Pazopanib—TAOK3—tendon—gout	6.74e-06	0.0454	CbGeAlD
Pazopanib—PDGFRA—tendon—gout	6.7e-06	0.0451	CbGeAlD
Pazopanib—MAP2K5—Signaling Pathways—POMC—gout	6.36e-06	0.000483	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—POMC—gout	6.2e-06	0.000471	CbGpPWpGaD
Pazopanib—KDR—tendon—gout	6.04e-06	0.0407	CbGeAlD
Pazopanib—MAP2K5—tendon—gout	6.04e-06	0.0407	CbGeAlD
Pazopanib—FGF1—Signaling Pathways—POMC—gout	5.91e-06	0.000449	CbGpPWpGaD
Pazopanib—CSF1R—tendon—gout	5.9e-06	0.0397	CbGeAlD
Pazopanib—CYP2C8—Metabolism—ABCG2—gout	5.52e-06	0.000419	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	5.31e-06	0.000403	CbGpPWpGaD
Pazopanib—PDGFRB—tendon—gout	5.23e-06	0.0352	CbGeAlD
Pazopanib—FGFR2—Signaling Pathways—POMC—gout	4.89e-06	0.000372	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ABCG2—gout	4.81e-06	0.000365	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—POMC—gout	4.81e-06	0.000365	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—POMC—gout	4.56e-06	0.000346	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—POMC—gout	4.55e-06	0.000345	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ABCG2—gout	4.53e-06	0.000344	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—gout	4.49e-06	0.000341	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—gout	4.12e-06	0.000313	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—gout	4.1e-06	0.000311	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—gout	4.01e-06	0.000305	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ABCG2—gout	3.84e-06	0.000292	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—gout	3.81e-06	0.000289	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	3.69e-06	0.00028	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—gout	3.29e-06	0.00025	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ABCG2—gout	2.96e-06	0.000225	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—gout	2.37e-06	0.00018	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—gout	2.06e-06	0.000156	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—gout	1.94e-06	0.000147	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—gout	1.65e-06	0.000125	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—gout	1.27e-06	9.64e-05	CbGpPWpGaD
